Journal
TRENDS IN PHARMACOLOGICAL SCIENCES
Volume 33, Issue 3, Pages 146-153Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2011.12.002
Keywords
-
Categories
Ask authors/readers for more resources
Therapeutic targeting of the processes that regulate histone modification is a growing area of scientific exploration. Although most interest has concentrated on the various families of enzymes that contribute to these processes, this review focuses on emerging data demonstrating the chemical tractability and therapeutic potential of a hitherto underexplored family of proteins, namely the bromodomain (BRD) family of reader proteins. These proteins perform a crucial role in translating histone modifications with powerful transcriptional consequences. We review current knowledge of the biology of this emergent target class and highlight recent breakthroughs that now make the BRD family of reader proteins attractive for drug discovery.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available